Medical Devices & Surgical Technology Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Devices & Surgical Technology Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Business & Finance
Clearant reports operating progress and 2005 financial results
April 11th, 2006
Clearant, Inc. (CLRI), developer of the patented CLEARANT PROCESS for pathogen inactivation, provided an update on the company's operating progress and reported financial results for 2005. "During 2005 Clearant successfully transitioned from a research and development phase with primarily one-time revenue events, to a commercial phase with recurring service and license revenue opportunities," said Alain Delongchamp, chief executive officer of Clearant. "Since 2004 more than 6,000 patients have received tissue allograft implants sterilized with the CLEARANT PROCESS, and we are focused on driving further acceptance in part owing to FDA's Good Tissue Practices, positive...
Source: Medical Devices & Surgical Technology Week (2006-04-11)
|
